VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q110029671 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010637.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q110029671‏
035 ‎‡a (OCoLC)Q110029671‏
100 0 ‎‡a Petra Schneider‏ ‎‡c chemist‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
670 ‎‡a Author's A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds‏
670 ‎‡a Author's Accessing new chemical entities through microfluidic systems‏
670 ‎‡a Author's Active learning for computational chemogenomics‏
670 ‎‡a Author's Aryl Bis-Sulfonamide Inhibitors of IspF fromArabidopsis thalianaandPlasmodium falciparum‏
670 ‎‡a Author's Chemically Advanced Template Search‏
670 ‎‡a Author's Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules‏
670 ‎‡a Author's Chemography of natural product space‏
670 ‎‡a Author's Combinatorial chemistry by ant colony optimization.‏
670 ‎‡a Author's Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands‏
670 ‎‡a Author's Common non-epigenetic drugs as epigenetic modulators‏
670 ‎‡a Author's Comparison of correlation vector methods for ligand-based similarity searching‏
670 ‎‡a Author's Coping with polypharmacology by computational medicinal chemistry‏
670 ‎‡a Author's Counting on natural products for drug design‏
670 ‎‡a Author's De Novo Design at the Edge of Chaos‏
670 ‎‡a Author's De Novo Fragment Design for Drug Discovery and Chemical Biology‏
670 ‎‡a Author's Deorphaning pyrrolopyrazines as potent multi-target antimalarial agents‏
670 ‎‡a Author's Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide‏
670 ‎‡a Author's Designing Multi-target Compound Libraries with Gaussian Process Models‏
670 ‎‡a Author's Development of a virtual screening method for identification of "frequent hitters" in compound libraries‏
670 ‎‡a Author's Distance phenomena in high-dimensional chemical descriptor spaces: consequences for similarity-based approaches‏
670 ‎‡a Author's Drugs by numbers: reaction-driven de novo design of potent and selective anticancer leads‏
670 ‎‡a Author's Engineering of a functional γ-tocopherol transfer protein‏
670 ‎‡a Author's Engineering of a functional γ-tocopherol transfer protein‏
670 ‎‡a Author's Erratum: Generative Recurrent Networks for De Novo Drug Design‏
670 ‎‡a Author's Exploring the chemical space of gamma-secretase modulators‏
670 ‎‡a Author's Exploring the Structural Space of the Galectin-1-Ligand Interaction‏
670 ‎‡a Author's Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors‏
670 ‎‡a Author's From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design‏
670 ‎‡a Author's From molecular shape to potent bioactive agents II: fragment-based de novo design‏
670 ‎‡a Author's From Virtual Screening to Bioactive Compounds by Visualizing and Clustering of Chemical Space‏
670 ‎‡a Author's Go with the flow: de-orphaning focused combinatorial libraries.‏
670 ‎‡a Author's Hybrid Network Model for "Deep Learning" of Chemical Data: Application to Antimicrobial Peptides‏
670 ‎‡a Author's Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening‏
670 ‎‡a Author's Identification of Synthetic Activators of Cancer Cell Migration by Hybrid Deep Learning‏
670 ‎‡a Author's Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus‏
670 ‎‡a Author's Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions‏
670 ‎‡a Author's Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia‏
670 ‎‡a Author's Macromolecular target prediction by self-organizing feature maps‏
670 ‎‡a Author's Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening‏
670 ‎‡a Author's Multi-objective molecular de novo design by adaptive fragment prioritization.‏
670 ‎‡a Author's Multidimensional Design of Anticancer Peptides.‏
670 ‎‡a Author's Native Electrospray Ionization Mass Spectrometry Reveals Multiple Facets of Aptamer-Ligand Interactions: From Mechanism to Binding Constants‏
670 ‎‡a Author's Neighborhood-Preserving Visualization of Adaptive Structure-Activity Landscapes: Application to Drug Discovery‏
670 ‎‡a Author's New allosteric modulators of metabotropic glutamate receptor 5‏
670 ‎‡a Author's New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening‏
670 ‎‡a Author's Peptide-Membrane Interaction between Targeting and Lysis‏
670 ‎‡a Author's Piloting the membranolytic activities of peptides with a self-organizing map.‏
670 ‎‡a Author's Polypharmacological Drug-target Inference for Chemogenomics‏
670 ‎‡a Author's Privileged Structures Revisited‏
670 ‎‡a Author's Rational Design of Membrane-Pore-Forming Peptides‏
670 ‎‡a Author's Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.‏
670 ‎‡a Author's Rethinking drug design in the artificial intelligence era‏
670 ‎‡a Author's Revealing the macromolecular targets of complex natural products‏
670 ‎‡a Author's Revealing the Macromolecular Targets of Fragment-Like Natural Products‏
670 ‎‡a Author's Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targets‏
670 ‎‡a Author's Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase‏
670 ‎‡a Author's Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction.‏
670 ‎‡a Author's Self-Organizing Molecular Fingerprints: A Ligand-Based View on Drug-Like Chemical Space and Off-Target Prediction‏
670 ‎‡a Author's Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors‏
670 ‎‡a Author's Structural insights on cholesterol endosynthesis: Binding of squalene and 2,3-oxidosqualene to supernatant protein factor‏
670 ‎‡a Author's Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation.‏
670 ‎‡a Author's Target Profile Prediction and Practical Evaluation of a Biginelli-Type Dihydropyrimidine Compound Library‏
670 ‎‡a Author's Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor‏
670 ‎‡a Author's Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor (PPAR) and Farnesoid X Receptor (FXR)‏
670 ‎‡a Author's Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors‏
670 ‎‡a Author's Targeting flexibility: a structure-based computational study revealing allosteric HIV-1 protease inhibitors.‏
670 ‎‡a Author's Virtual screening for compounds that mimic protein-protein interface epitopes‏
670 ‎‡a Author's Virtual screening for PPAR modulators using a probabilistic neural network‏
670 ‎‡a Author's Voyages to the (un)known: adaptive design of bioactive compounds‏
919 ‎‡a identifyingthemacromoleculartargetsofdenovodesignedchemicalentitiesthroughselforganizingmapconsensus‏ ‎‡A Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus‏ ‎‡9 1‏
919 ‎‡a multiobjectivemoleculardenovodesignbyadaptivefragmentprioritization‏ ‎‡A Multi-objective molecular de novo design by adaptive fragment prioritization.‏ ‎‡9 1‏
919 ‎‡a multidimensionaldesignofanticancerpeptides‏ ‎‡A Multidimensional Design of Anticancer Peptides.‏ ‎‡9 1‏
919 ‎‡a neighborhoodpreservingvisualizationofadaptivestructureactivitylandscapesapplicationtodrugdiscovery‏ ‎‡A Neighborhood-Preserving Visualization of Adaptive Structure-Activity Landscapes: Application to Drug Discovery‏ ‎‡9 1‏
919 ‎‡a fromvirtualscreeningtobioactivecompoundsbyvisualizingandclusteringofchemicalspace‏ ‎‡A From Virtual Screening to Bioactive Compounds by Visualizing and Clustering of Chemical Space‏ ‎‡9 1‏
919 ‎‡a 5withtheflowdeorphaningfocusedcombinatoriallibraries‏ ‎‡A Go with the flow: de-orphaning focused combinatorial libraries.‏ ‎‡9 1‏
919 ‎‡a newallostericmodulatorsofmetabotropicglutamatereceptor5‏ ‎‡A New allosteric modulators of metabotropic glutamate receptor 5‏ ‎‡9 1‏
919 ‎‡a newallostericmodulatorsofmetabotropicglutamatereceptor5mglur5foundbyligandbasedvirtualscreening‏ ‎‡A New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening‏ ‎‡9 1‏
919 ‎‡a peptidemembraneinteractionbetweentargetingandlysis‏ ‎‡A Peptide-Membrane Interaction between Targeting and Lysis‏ ‎‡9 1‏
919 ‎‡a voyagestothe1knownadaptivedesignofbioactivecompounds‏ ‎‡A Voyages to the (un)known: adaptive design of bioactive compounds‏ ‎‡9 1‏
919 ‎‡a virtualscreeningforpparmodulatorsusingaprobabilisticneuralnetwork‏ ‎‡A Virtual screening for PPAR modulators using a probabilistic neural network‏ ‎‡9 1‏
919 ‎‡a chemicallyadvancedtemplatesearch‏ ‎‡A Chemically Advanced Template Search‏ ‎‡9 1‏
919 ‎‡a inhibitorsofhelicobacterpyloriproteasehtrafoundbyvirtualligandscreeningcombatbacterialinvasionofepithelia‏ ‎‡A Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia‏ ‎‡9 1‏
919 ‎‡a matrixbasedmoleculardescriptorsforprospectivevirtualcompoundscreening‏ ‎‡A Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening‏ ‎‡9 1‏
919 ‎‡a chemicallyadvancedtemplatesearchcatsforscaffoldhoppingandprospectivetargetpredictionfororphanmolecules‏ ‎‡A Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules‏ ‎‡9 1‏
919 ‎‡a distancephenomenainhighdimensionalchemicaldescriptorspacesconsequencesforsimilaritybasedapproaches‏ ‎‡A Distance phenomena in high-dimensional chemical descriptor spaces: consequences for similarity-based approaches‏ ‎‡9 1‏
919 ‎‡a computationalmethodforunveilingthetargetpromiscuityofpharmacologicallyactivecompounds‏ ‎‡A A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds‏ ‎‡9 1‏
919 ‎‡a chemographyofnaturalproductspace‏ ‎‡A Chemography of natural product space‏ ‎‡9 1‏
919 ‎‡a novodesignattheedgeofchaos‏ ‎‡A De Novo Design at the Edge of Chaos‏ ‎‡9 1‏
919 ‎‡a accessingnewchemicalentitiesthroughmicrofluidicsystems‏ ‎‡A Accessing new chemical entities through microfluidic systems‏ ‎‡9 1‏
919 ‎‡a macromoleculartargetpredictionbyselforganizingfeaturemaps‏ ‎‡A Macromolecular target prediction by self-organizing feature maps‏ ‎‡9 1‏
919 ‎‡a nativeelectrosprayionizationmassspectrometryrevealsmultiplefacetsofaptamerligandinteractionsfrommechanismtobindingconstants‏ ‎‡A Native Electrospray Ionization Mass Spectrometry Reveals Multiple Facets of Aptamer-Ligand Interactions: From Mechanism to Binding Constants‏ ‎‡9 1‏
919 ‎‡a hybridnetworkmodelfordeeplearningofchemicaldataapplicationtoantimicrobialpeptides‏ ‎‡A Hybrid Network Model for "Deep Learning" of Chemical Data: Application to Antimicrobial Peptides‏ ‎‡9 1‏
919 ‎‡a activelearningforcomputationalchemogenomics‏ ‎‡A Active learning for computational chemogenomics‏ ‎‡9 1‏
919 ‎‡a frommolecularshapetopotentbioactiveagents2fragmentbaseddenovodesign‏ ‎‡A From molecular shape to potent bioactive agents II: fragment-based de novo design‏ ‎‡9 1‏
919 ‎‡a fromcomplexnaturalproductstosimplesyntheticmimeticsbycomputationaldenovodesign‏ ‎‡A From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design‏ ‎‡9 1‏
919 ‎‡a extractionandvisualizationofpotenti Alpha rmacophorepointsusingsupportvectormachinesapplicationtoligandbasedvirtualscreeningforcox2inhibitors‏ ‎‡A Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors‏ ‎‡9 1‏
919 ‎‡a exploringthestructuralspaceofthegalectin1ligandinteraction‏ ‎‡A Exploring the Structural Space of the Galectin-1-Ligand Interaction‏ ‎‡9 1‏
919 ‎‡a arylbissulfonamideinhibitorsofispffromarabidopsisthalianaandplasmodiumfalciparum‏ ‎‡A Aryl Bis-Sulfonamide Inhibitors of IspF fromArabidopsis thalianaandPlasmodium falciparum‏ ‎‡9 1‏
919 ‎‡a exploringthechemicalspaceofgammasecretasemodulators‏ ‎‡A Exploring the chemical space of gamma-secretase modulators‏ ‎‡9 1‏
919 ‎‡a erratumgenerativerecurrentnetworksfordenovodrugdesign‏ ‎‡A Erratum: Generative Recurrent Networks for De Novo Drug Design‏ ‎‡9 1‏
919 ‎‡a engineeringofafunctionalγtocopheroltransferprotein‏ ‎‡A Engineering of a functional γ-tocopherol transfer protein‏ ‎‡9 1‏
919 ‎‡a polypharmacologicaldrugtargetinferenceforchemogenomics‏ ‎‡A Polypharmacological Drug-target Inference for Chemogenomics‏ ‎‡9 1‏
919 ‎‡a privilegedstructuresrevisited‏ ‎‡A Privileged Structures Revisited‏ ‎‡9 1‏
919 ‎‡a rationaldesignofmembraneporeformingpeptides‏ ‎‡A Rational Design of Membrane-Pore-Forming Peptides‏ ‎‡9 1‏
919 ‎‡a reactiondrivendenovodesignsynthesisandtestingofpotentialtype2kinaseinhibitors‏ ‎‡A Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.‏ ‎‡9 1‏
919 ‎‡a rethinkingdrugdesignintheartificialintelligenceera‏ ‎‡A Rethinking drug design in the artificial intelligence era‏ ‎‡9 1‏
919 ‎‡a revealingthemacromoleculartargetsofcomplexnaturalproducts‏ ‎‡A Revealing the macromolecular targets of complex natural products‏ ‎‡9 1‏
919 ‎‡a revealingthemacromoleculartargetsoffragmentlikenaturalproducts‏ ‎‡A Revealing the Macromolecular Targets of Fragment-Like Natural Products‏ ‎‡9 1‏
919 ‎‡a scaffoldhoppingbyfuzzypharmacophoresanditsapplicationtornatargets‏ ‎‡A Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targets‏ ‎‡9 1‏
919 ‎‡a scaffoldhoppingcascadeyieldspotentinhibitorsof5lipoxygenase‏ ‎‡A Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase‏ ‎‡9 1‏
919 ‎‡a scoringofdenovodesignedchemicalentitiesbymacromoleculartargetprediction‏ ‎‡A Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction.‏ ‎‡9 1‏
919 ‎‡a selforganizingmolecularfingerprintsaligandbasedviewondruglikechemicalspaceandofftargetprediction‏ ‎‡A Self-Organizing Molecular Fingerprints: A Ligand-Based View on Drug-Like Chemical Space and Off-Target Prediction‏ ‎‡9 1‏
919 ‎‡a sphericalharmonicscoefficientsforligandbasedvirtualscreeningofcyclooxygenaseinhibitors‏ ‎‡A Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors‏ ‎‡9 1‏
919 ‎‡a structuralinsightsoncholesterolendosynthesisbindingofsqualeneand23oxidosqualenetosupernatantproteinfactor‏ ‎‡A Structural insights on cholesterol endosynthesis: Binding of squalene and 2,3-oxidosqualene to supernatant protein factor‏ ‎‡9 1‏
919 ‎‡a targetpredictionbycascadedselforganizingmapsforliganddeorphaningandsideeffectinvestigation‏ ‎‡A Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation.‏ ‎‡9 1‏
919 ‎‡a targetprofilepredictionandpracticalevaluationofabiginellitypedihydropyrimidinecompoundlibrary‏ ‎‡A Target Profile Prediction and Practical Evaluation of a Biginelli-Type Dihydropyrimidine Compound Library‏ ‎‡9 1‏
919 ‎‡a engineeringofafunctionali3tocopheroltransferprotein‏ ‎‡A Engineering of a functional γ-tocopherol transfer protein‏ ‎‡9 1‏
919 ‎‡a drugsbynumbersreactiondrivendenovodesignofpotentandselectiveanticancerleads‏ ‎‡A Drugs by numbers: reaction-driven de novo design of potent and selective anticancer leads‏ ‎‡9 1‏
919 ‎‡a identificationofnaturalproductderivedinhibitorsof5lipoxygenaseactivitybyligandbasedvirtualscreening‏ ‎‡A Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening‏ ‎‡9 1‏
919 ‎‡a combinatorialchemistrybyantcolonyoptimization‏ ‎‡A Combinatorial chemistry by ant colony optimization.‏ ‎‡9 1‏
919 ‎‡a developmentofavirtualscreeningmethodforidentificationoffrequenthittersincompoundlibraries‏ ‎‡A Development of a virtual screening method for identification of "frequent hitters" in compound libraries‏ ‎‡9 1‏
919 ‎‡a designingmultitargetcompoundlibrarieswithgaussianprocessmodels‏ ‎‡A Designing Multi-target Compound Libraries with Gaussian Process Models‏ ‎‡9 1‏
919 ‎‡a identificationofsyntheticactivatorsofcancercellmigrationbyhybriddeeplearning‏ ‎‡A Identification of Synthetic Activators of Cancer Cell Migration by Hybrid Deep Learning‏ ‎‡9 1‏
919 ‎‡a pilotingthemembranolyticactivitiesofpeptideswithaselforganizingmap‏ ‎‡A Piloting the membranolytic activities of peptides with a self-organizing map.‏ ‎‡9 1‏
919 ‎‡a combiningonchipsynthesisofafocusedcombinatoriallibrarywithcomputationaltargetpredictionrevealsimidazopyridinegpcrligands‏ ‎‡A Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands‏ ‎‡9 1‏
919 ‎‡a comparisonofcorrelationvectormethodsforligandbasedsimilaritysearching‏ ‎‡A Comparison of correlation vector methods for ligand-based similarity searching‏ ‎‡9 1‏
919 ‎‡a copingwithpolypharmacologybycomputationalmedicinalchemistry‏ ‎‡A Coping with polypharmacology by computational medicinal chemistry‏ ‎‡9 1‏
919 ‎‡a countingonnaturalproductsfordrugdesign‏ ‎‡A Counting on natural products for drug design‏ ‎‡9 1‏
919 ‎‡a commonnonepigeneticdrugsasepigeneticmodulators‏ ‎‡A Common non-epigenetic drugs as epigenetic modulators‏ ‎‡9 1‏
919 ‎‡a novofragmentdesignfordrugdiscoveryandchemicalbiology‏ ‎‡A De Novo Fragment Design for Drug Discovery and Chemical Biology‏ ‎‡9 1‏
919 ‎‡a deorphaningpyrrolopyrazinesaspotentmultitargetantimalarialagents‏ ‎‡A Deorphaning pyrrolopyrazines as potent multi-target antimalarial agents‏ ‎‡9 1‏
919 ‎‡a deorphaningthemacromoleculartargetsofthenaturalanticancercompounddoliculide‏ ‎‡A Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide‏ ‎‡9 1‏
919 ‎‡a immunosuppressivesmallmoleculediscoveredbystructurebasedvirtualscreeningforinhibitorsofproteinproteininteractions‏ ‎‡A Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions‏ ‎‡9 1‏
919 ‎‡a targetprofilepredictioncrossactivationofperoxisomeproliferatoractivatedreceptor‏ ‎‡A Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor‏ ‎‡9 1‏
919 ‎‡a targetprofilepredictioncrossactivationofperoxisomeproliferatoractivatedreceptorpparandfarnesoid10receptorfxr‏ ‎‡A Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor (PPAR) and Farnesoid X Receptor (FXR)‏ ‎‡9 1‏
919 ‎‡a targetingdynamicpocketsofhiv1proteasebystructurebasedcomputationalscreeningforallostericinhibitors‏ ‎‡A Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors‏ ‎‡9 1‏
919 ‎‡a targetingflexibilityastructurebasedcomputationalstudyrevealingallosterichiv1proteaseinhibitors‏ ‎‡A Targeting flexibility: a structure-based computational study revealing allosteric HIV-1 protease inhibitors.‏ ‎‡9 1‏
919 ‎‡a virtualscreeningforcompoundsthatmimicproteinproteininterfaceepitopes‏ ‎‡A Virtual screening for compounds that mimic protein-protein interface epitopes‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BIBSYS|90547535‏
996 ‎‡2 BAV|495_283275‏
996 ‎‡2 NTA|204345235‏
996 ‎‡2 LC|n 82256125‏
996 ‎‡2 SZ|1013764994‏
996 ‎‡2 SZ|118758675‏
996 ‎‡2 RERO|A026927136‏
996 ‎‡2 DNB|1177267225‏
996 ‎‡2 NTA|069314608‏
996 ‎‡2 NII|DA02428858‏
996 ‎‡2 DNB|1247304531‏
996 ‎‡2 ISNI|0000000108968372‏
996 ‎‡2 NTA|153847409‏
996 ‎‡2 NTA|173989195‏
996 ‎‡2 DNB|1292520019‏
996 ‎‡2 NKC|ola2003188486‏
996 ‎‡2 RERO|A005671603‏
996 ‎‡2 LC|n 85352425‏
996 ‎‡2 SUDOC|132707608‏
996 ‎‡2 ERRR|a12526769‏
996 ‎‡2 SUDOC|244357889‏
996 ‎‡2 DNB|1037030001‏
996 ‎‡2 DNB|172778441‏
996 ‎‡2 ISNI|000000005733765X‏
996 ‎‡2 DNB|129272000‏
996 ‎‡2 DNB|118609610‏
996 ‎‡2 LC|n 84069360‏
996 ‎‡2 DNB|1177719479‏
996 ‎‡2 DNB|1019875887‏
996 ‎‡2 ERRR|a1252671x‏
996 ‎‡2 DNB|136465056‏
996 ‎‡2 RERO|A012810219‏
996 ‎‡2 DNB|102999708X‏
996 ‎‡2 SUDOC|071563105‏
996 ‎‡2 DNB|1109807252‏
996 ‎‡2 ISNI|0000000365798474‏
996 ‎‡2 KRNLK|KAC199624464‏
996 ‎‡2 DNB|131358936‏
996 ‎‡2 PLWABN|9810550789405606‏
996 ‎‡2 RERO|A018912406‏
996 ‎‡2 DNB|121313336‏
996 ‎‡2 DE633|pe30073746‏
996 ‎‡2 ISNI|0000000114501787‏
996 ‎‡2 SUDOC|270510974‏
996 ‎‡2 LC|no2001070549‏
996 ‎‡2 BIBSYS|90638953‏
996 ‎‡2 ISNI|0000000008648726‏
996 ‎‡2 NTA|072000791‏
996 ‎‡2 NUKAT|n 2002067672‏
996 ‎‡2 SUDOC|028422929‏
996 ‎‡2 BNE|XX1733658‏
996 ‎‡2 ISNI|0000000109209087‏
996 ‎‡2 NTA|156233401‏
996 ‎‡2 NDL|00474620‏
996 ‎‡2 SUDOC|03074377X‏
996 ‎‡2 DNB|1226383505‏
996 ‎‡2 SZ|1104507927‏
996 ‎‡2 DNB|1100315861‏
996 ‎‡2 NKC|xx0215647‏
996 ‎‡2 NUKAT|n 2006132720‏
996 ‎‡2 LC|no2007146657‏
996 ‎‡2 ISNI|0000000021185957‏
996 ‎‡2 NKC|jn20000604935‏
996 ‎‡2 NUKAT|n 2006078825‏
996 ‎‡2 NLA|000035481831‏
996 ‎‡2 ISNI|0000000072171125‏
996 ‎‡2 BNF|12194942‏
996 ‎‡2 SZ|1104496763‏
996 ‎‡2 SUDOC|030273897‏
996 ‎‡2 NTA|070227020‏
996 ‎‡2 J9U|987007278108705171‏
996 ‎‡2 ISNI|0000000018057209‏
996 ‎‡2 NSK|000779802‏
996 ‎‡2 BNCHL|10000000000000000167877‏
996 ‎‡2 SZ|1104502410‏
996 ‎‡2 DNB|1026908272‏
996 ‎‡2 NSK|000040378‏
996 ‎‡2 DNB|1192684869‏
996 ‎‡2 DNB|140533796‏
996 ‎‡2 DNB|1281784834‏
996 ‎‡2 SZ|137608616‏
996 ‎‡2 ERRR|a1252668x‏
996 ‎‡2 CAOONL|ncf10367758‏
996 ‎‡2 DNB|129271993‏
996 ‎‡2 SUDOC|128189711‏
996 ‎‡2 SUDOC|192987283‏
996 ‎‡2 SUDOC|188619658‏
996 ‎‡2 NTA|154992062‏
996 ‎‡2 DNB|1013764994‏
996 ‎‡2 ISNI|0000000000734363‏
996 ‎‡2 PLWABN|9813218058105606‏
996 ‎‡2 CAOONL|ncf11179811‏
996 ‎‡2 DNB|1233365037‏
996 ‎‡2 RERO|A027786419‏
996 ‎‡2 DNB|1105782689‏
996 ‎‡2 RERO|A003803432‏
996 ‎‡2 RERO|A003803433‏
996 ‎‡2 RERO|A003803435‏
996 ‎‡2 RERO|A003803436‏
996 ‎‡2 DNB|1046852426‏
996 ‎‡2 RERO|A012522637‏
996 ‎‡2 DNB|1104496763‏
996 ‎‡2 DNB|1206595426‏
996 ‎‡2 NII|DA04009007‏
996 ‎‡2 PLWABN|9810702510605606‏
996 ‎‡2 J9U|987007314100905171‏
996 ‎‡2 NTA|068451148‏
996 ‎‡2 JPG|500235873‏
996 ‎‡2 DNB|1037029453‏
996 ‎‡2 ISNI|0000000434841297‏
996 ‎‡2 ISNI|0000000081448077‏
996 ‎‡2 DNB|1016931794‏
996 ‎‡2 ISNI|0000000051232822‏
996 ‎‡2 ISNI|0000000013400397‏
996 ‎‡2 J9U|987007355362905171‏
996 ‎‡2 ISNI|0000000108918367‏
996 ‎‡2 LC|nr2006001627‏
996 ‎‡2 ISNI|0000000108589954‏
996 ‎‡2 RERO|A012315811‏
996 ‎‡2 ISNI|0000000024361450‏
996 ‎‡2 ISNI|0000000120369487‏
996 ‎‡2 NKC|pna20211101747‏
996 ‎‡2 LC|no2010055173‏
996 ‎‡2 BNE|XX1691536‏
996 ‎‡2 NUKAT|n 2008093787‏
996 ‎‡2 DNB|138907250‏
996 ‎‡2 BIBSYS|90346556‏
996 ‎‡2 DNB|131784501‏
996 ‎‡2 NUKAT|n 2005118433‏
996 ‎‡2 DNB|133945189‏
996 ‎‡2 DNB|116836989‏
996 ‎‡2 DNB|131880918‏
996 ‎‡2 RERO|A012331944‏
996 ‎‡2 LC|n 94073572‏
996 ‎‡2 DNB|133470938‏
996 ‎‡2 JPG|500242600‏
996 ‎‡2 DNB|1075056802‏
996 ‎‡2 DNB|1021026123‏
996 ‎‡2 LIH|LNB:B__8W;=BH‏
996 ‎‡2 LC|nb2013006529‏
996 ‎‡2 SUDOC|243480342‏
996 ‎‡2 DNB|139715444‏
996 ‎‡2 DNB|1329921127‏
996 ‎‡2 RERO|A012354468‏
996 ‎‡2 SUDOC|118708406‏
996 ‎‡2 J9U|987007451322705171‏
996 ‎‡2 SUDOC|168626047‏
996 ‎‡2 DNB|105645704X‏
996 ‎‡2 LC|n 86873768‏
996 ‎‡2 NTA|069005249‏
996 ‎‡2 J9U|987007267779105171‏
996 ‎‡2 CAOONL|ncf11402978‏
996 ‎‡2 DNB|1069168351‏
996 ‎‡2 SZ|1109807252‏
996 ‎‡2 J9U|987007528260005171‏
996 ‎‡2 NUKAT|n 2019000104‏
996 ‎‡2 NTA|228033268‏
996 ‎‡2 BIBSYS|90903700‏
996 ‎‡2 LC|n 82081210‏
996 ‎‡2 DNB|128630906‏
996 ‎‡2 DNB|1248747372‏
996 ‎‡2 NII|DA07478944‏
996 ‎‡2 DNB|138176728‏
996 ‎‡2 NUKAT|n 2019015379‏
996 ‎‡2 NUKAT|n 2007089603‏
996 ‎‡2 NTA|168759349‏
996 ‎‡2 NTA|327187549‏
996 ‎‡2 PLWABN|9810600557705606‏
996 ‎‡2 DNB|131358898‏
996 ‎‡2 SUDOC|08024629X‏
996 ‎‡2 DNB|120813653‏
996 ‎‡2 LIH|LNB:CX_d__a_;=B_w_‏
996 ‎‡2 LC|no2011195447‏
996 ‎‡2 ISNI|0000000108959951‏
996 ‎‡2 NII|DA09600787‏
996 ‎‡2 DNB|1037047524‏
996 ‎‡2 RERO|A026880088‏
996 ‎‡2 DNB|115116769X‏
996 ‎‡2 DNB|1019875720‏
996 ‎‡2 NUKAT|n 2010115097‏
996 ‎‡2 DNB|123543525‏
996 ‎‡2 DNB|172361540‏
996 ‎‡2 LC|no2012019887‏
996 ‎‡2 ISNI|0000000066820475‏
996 ‎‡2 NUKAT|n 2017087061‏
996 ‎‡2 DNB|1104496097‏
996 ‎‡2 DNB|1200971418‏
996 ‎‡2 RERO|A026875157‏
996 ‎‡2 LC|nr 93044089‏
996 ‎‡2 LC|n 94096293‏
996 ‎‡2 ISNI|0000000456805887‏
996 ‎‡2 PLWABN|9810685025405606‏
996 ‎‡2 NUKAT|n 2010048681‏
996 ‎‡2 RERO|A012401702‏
996 ‎‡2 DNB|1066924082‏
996 ‎‡2 DNB|136055699‏
996 ‎‡2 VLACC|000029060‏
996 ‎‡2 SUDOC|116429941‏
996 ‎‡2 DNB|125452195‏
996 ‎‡2 DNB|1035133318‏
996 ‎‡2 DNB|173022405‏
996 ‎‡2 NUKAT|n 2010041405‏
996 ‎‡2 CAOONL|ncf12141354‏
996 ‎‡2 CAOONL|ncf11493585‏
996 ‎‡2 CAOONL|ncf11753982‏
996 ‎‡2 DNB|135767237‏
996 ‎‡2 SUDOC|03055764X‏
996 ‎‡2 RERO|A012333354‏
996 ‎‡2 ISNI|0000000390970782‏
996 ‎‡2 NUKAT|n 2012267850‏
996 ‎‡2 ISNI|0000000123478777‏
996 ‎‡2 LC|n 87101124‏
996 ‎‡2 J9U|987007274580505171‏
996 ‎‡2 DNB|137674198‏
996 ‎‡2 RERO|A013891854‏
996 ‎‡2 NLA|000035481825‏
996 ‎‡2 DNB|1035132079‏
996 ‎‡2 BNF|12026125‏
996 ‎‡2 ISNI|0000000076921595‏
996 ‎‡2 NUKAT|n 2012263969‏
996 ‎‡2 ISNI|0000000074557064‏
996 ‎‡2 DNB|137608616‏
996 ‎‡2 RERO|A026880093‏
996 ‎‡2 BIBSYS|3073796‏
996 ‎‡2 DNB|1049727053‏
996 ‎‡2 DNB|1013768965‏
996 ‎‡2 LC|no2002098751‏
996 ‎‡2 SZ|13135891X‏
996 ‎‡2 DNB|1104507927‏
996 ‎‡2 LC|nb2012004870‏
996 ‎‡2 LC|n 89628186‏
996 ‎‡2 ISNI|0000000012504311‏
996 ‎‡2 NKC|xx0009590‏
996 ‎‡2 NTA|133344568‏
996 ‎‡2 SUDOC|230824587‏
996 ‎‡2 SZ|1104496097‏
996 ‎‡2 LC|n 79080102‏
996 ‎‡2 LIH|LNB:,_a_,;=BN‏
996 ‎‡2 DNB|1290485798‏
996 ‎‡2 DNB|120432283X‏
996 ‎‡2 NII|DA02792158‏
996 ‎‡2 NKC|zcu2013770947‏
996 ‎‡2 J9U|987007320082105171‏
996 ‎‡2 BLBNB|000347287‏
996 ‎‡2 DNB|125452179‏
996 ‎‡2 LC|n 92028620‏
996 ‎‡2 DE633|pe41014508‏
996 ‎‡2 ISNI|0000000016052017‏
996 ‎‡2 RERO|A012433981‏
996 ‎‡2 DNB|1136588035‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏